EUVIMEDEUVIMED entdecken
Crossref

Gigantol enhances chemosensitivity to cisplatin in oral squamous cell carcinoma through the PI3K/AKT/NF-κB pathway

HanQing Hu, Chang Chen, Fengrui Zhang, XiaoLi Lu

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas · 30.01.2026 · 25 (1) · 26-44

DOI: 10.37360/blacpma.26.25.1.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, online erschienen am 30.01.2026. Verfasst von HanQing Hu und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate Gigantol (GGT)'s potential to increase Cisplatin (CDDP) sensitivity in CDDP-resistant Oral squamous cell carcinoma (OSCC). Cell proliferation, migration and invasion were analyzed through cell counting kit-8 (CCK-8), EdU staining, colony formation, wound healing and Transwell assays. Apoptosis was assessed by Hoechst 33258 staining and flow cytometry. A nude mouse OSCC tumor model was constructed. PI3K/AKT/NF-κB pathway, epithelial-mesenchymal transition (EMT) and apoptosis-related protein levels were assessed via Western blot. Results showed that GGT and CDDP arrested the CAL27/CDDP at the G2/M phase, and reduced EdU+ cells and colony numbers. GGT increased the apoptosis rate, inhibited EMT, reduced wound healing rate and invasive cells. Molecularly, GGT hindered PI3K/AKT/NF-κB pathway, the PI3K agonist inverted the actions of GGT, inhibiting apoptosis and promoting EMT. In conclusion, GGT increasesOSCC sensitivity to CDDP by inhibiting PI3K/AKT/NF-κB pathway, presenting a novel clinical treatment strategy for OSCC.

Zitieren

APA

Hu, H., Chen, C., Zhang, F., & Lu, X. (2026). Gigantol enhances chemosensitivity to cisplatin in oral squamous cell carcinoma through the PI3K/AKT/NF-κB pathway. Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, 25(1), 26-44. https://doi.org/10.37360/blacpma.26.25.1.3

Vancouver

Hu H, Chen C, Zhang F, Lu X. Gigantol enhances chemosensitivity to cisplatin in oral squamous cell carcinoma through the PI3K/AKT/NF-κB pathway. Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas. 2026;25(1):26-44. doi:10.37360/blacpma.26.25.1.3

BibTeX
@article{Hu2026,
  author = {Hu, HanQing and Chen, Chang and Zhang, Fengrui and Lu, XiaoLi},
  title = {Gigantol enhances chemosensitivity to cisplatin in oral squamous cell carcinoma through the PI3K/AKT/NF-κB pathway},
  journal = {Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas},
  year = {2026},
  volume = {25},
  number = {1},
  pages = {26--44},
  doi = {10.37360/blacpma.26.25.1.3}
}
Kostenlos starten →